psychedelics-investing Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
psychedelics-investing Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
psychedelics-investing Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
psychedelics-investing Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
psychedelics-investing Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
psychedelics-investing Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
psychedelics-investing Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global
African Discovery Group announces signing of Definitive Sales and Purchase Agreement for Butembo Copper Asset in the Democratic Republic of Congo; name change to Copper Intelligence, Inc
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve "Project Vault" and Highlights Titanium's Strategic Importance to North American Defense Supply Chains
